GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » China Regenerative Medicine International Ltd (HKSE:08158) » Definitions » Short-Term Debt

China Regenerative Medicine International (HKSE:08158) Short-Term Debt : HK$19.63 Mil (As of Jun. 2024)


View and export this data going back to 2001. Start your Free Trial

What is China Regenerative Medicine International Short-Term Debt?

China Regenerative Medicine International's Short-Term Debt for the quarter that ended in Jun. 2024 was HK$19.63 Mil.

China Regenerative Medicine International's quarterly Short-Term Debt increased from Sep. 2023 (HK$0.00 Mil) to Dec. 2023 (HK$13.63 Mil) and increased from Dec. 2023 (HK$13.63 Mil) to Jun. 2024 (HK$19.63 Mil).

China Regenerative Medicine International's annual Short-Term Debt increased from Dec. 2021 (HK$29.95 Mil) to Dec. 2022 (HK$48.41 Mil) but then declined from Dec. 2022 (HK$48.41 Mil) to Dec. 2023 (HK$13.63 Mil).


China Regenerative Medicine International Short-Term Debt Historical Data

The historical data trend for China Regenerative Medicine International's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Regenerative Medicine International Short-Term Debt Chart

China Regenerative Medicine International Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.17 20.30 29.95 48.41 13.63

China Regenerative Medicine International Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 51.44 - 13.63 19.63

China Regenerative Medicine International Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


China Regenerative Medicine International Short-Term Debt Related Terms

Thank you for viewing the detailed overview of China Regenerative Medicine International's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


China Regenerative Medicine International Business Description

Traded in Other Exchanges
N/A
Address
132 Nathan Road, Suite 2310-18, Miramar Tower, Tsim Sha Tsui, Kowloon, HKG
China Regenerative Medicine International Ltd is an investment holding company engaged in the provision of healthcare products and services. Its reportable segments are Aesthetic medical and beauty services and Medical services. The vast majority of the company's revenue is derived from its Aesthetic medical and beauty services segment. Geographically, the People's Republic of China accounts for the majority of the revenue. It also has a presence in Hong Kong.
Executives
Central Huijin Investment Ltd. 2201 Interest of corporation controlled by you
Wang Chuang 2101 Beneficial owner
Arab Osman Mohammed 2501 Other
Wong Kwok Keung 2501 Other
Lei Changjuan 2101 Beneficial owner
Chang Zhou Shi Zhong Min Xing Kong Qi Ye Guan Li Zi Xun Fu Wu He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Kong Yudong 2101 Beneficial owner
Chang Zhou Shi Yao Guang Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Li Ren 2201 Interest of corporation controlled by you
Nat-ace Wood Industry Ltd. (formerly Known As Forerunner Technology Limited) 2201 Interest of corporation controlled by you
All Favour Holdings Limited 2101 Beneficial owner
Deng Shufen 2202 Interest of your spouse
Dai Yumin 2201 Interest of corporation controlled by you
Wang Xiaogang 2101 Beneficial owner
China Orient Asset Management Co., Ltd. 2106 Person having a security interest in shares

China Regenerative Medicine International Headlines

No Headlines